InflaRx NV (IFRX)
2.035
+0.32
(+19.01%)
USD |
NASDAQ |
Nov 14, 16:00
2.08
+0.04
(+2.21%)
After-Hours: 18:11
InflaRx Revenue (Quarterly): 0.0068M for June 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 0.0068M |
| March 31, 2024 | 0.0391M |
| Date | Value |
|---|---|
| December 31, 2023 | 0.0025M |
| September 30, 2023 | 0.0662M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.0025M
Minimum
Dec 2023
0.0662M
Maximum
Sep 2023
0.0287M
Average
0.023M
Median
Revenue (Quarterly) Benchmarks
| Affimed NV | 0.1658M |
| BioNTech SE | 1.369B |
| Immatics NV | 20.19M |
| CureVac NV | 15.54M |
| ATAI Life Sciences NV | 0.273M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -14.91M |
| Total Expenses (Quarterly) | 16.59M |
| EPS Diluted (Quarterly) | -0.2584 |
| Enterprise Value | 20.31M |
| Gross Profit Margin (Quarterly) | -5.38K% |
| Profit Margin (Quarterly) | -217.8K% |
| Earnings Yield | -43.55% |
| Normalized Earnings Yield | -44.54 |